In December 2015， Hong Kong WD Pharmaceutical Co., Limited was Incorporated in Hong Kong.
In January 2016, Shanghai WD Pharmaceutical Co. (WDP), a wholly owned subsidiary of Hong Kong WD Pharmaceutical Co., was registered in Shanghai Zhangjiang Hi-Tech Park.
In December 2019, WDP secured Series A investment from Baifu Health.
In March 2021, WDP received Series B funding from Shanghai Fudan Zhangjiang Biomedicine Co., LTD and Shanghai GP Healthcare Venture Capital Fund.
